Balasa Dinverno & Foltz LLC Biogen Inc. Transaction History

Balasa Dinverno & Foltz LLC

$1.58 Billion
Q3 2022

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 25, 2022	SELL	$193.77 - $244.14 $262,170 - $330,321	-1,353 Closed	0 $0
Q4 2021 Jan 26, 2022	SELL	$223.92 - $287.77 $214,963 - $276,259	-960 Reduced 41.5%	1,353 $325,000
Q3 2021 Oct 26, 2021	BUY	$282.99 - $369.05 $848 - $1,107	3 Added 0.13%	2,313 $655,000
Q2 2021 Jul 23, 2021	SELL	$259.0 - $414.71 $227,920 - $364,944	-880 Reduced 27.59%	2,310 $800,000
Q1 2021 Apr 29, 2021	SELL	$242.95 - $284.63 $298,099 - $349,241	-1,227 Reduced 27.78%	3,190 $892,000
Q4 2020 Jan 26, 2021	SELL	$236.26 - $355.63 $647,352 - $974,426	-2,740 Reduced 38.28%	4,417 $1.08 Million
Q3 2020 Nov 10, 2020	SELL	$264.77 - $305.71 $190,899 - $220,416	-721 Reduced 9.15%	7,157 $2.03 Million
Q2 2020 Aug 07, 2020	SELL	$258.66 - $342.55 $2.47 Million - $3.27 Million	-9,547 Closed	0 $0
Q1 2020 Apr 30, 2020	BUY	$268.85 - $341.04 $922,424 - $1.17 Million	3,431 Added 56.1%	9,547 $3.02 Million
Q4 2019 Jan 22, 2020	BUY	$220.06 - $304.07 $324,368 - $448,199	1,474 Added 31.75%	6,116 $1.82 Million
Q3 2019 Nov 06, 2019	BUY	$217.44 - $243.88 $804,093 - $901,868	3,698 Added 391.74%	4,642 $1.08 Million
Q2 2019 Aug 07, 2019	SELL	$219.29 - $241.72 $233,763 - $257,673	-1,066 Reduced 53.03%	944 $221,000
Q1 2019 May 10, 2019	BUY	$216.71 - $338.96 $38,791 - $60,673	179 Added 9.78%	2,010 $475,000
Q4 2018 Feb 04, 2019	BUY	$278.5 - $352.75 $12,532 - $15,873	45 Added 2.52%	1,831 $551,000
Q3 2018 Oct 24, 2018	BUY	$293.51 - $383.83 $1,174 - $1,535	4 Added 0.22%	1,786 $631,000
Q2 2018 Aug 01, 2018	BUY	$257.52 - $306.91 $163,782 - $195,194	636 Added 55.5%	1,782 $517,000
Q1 2018 Apr 23, 2018	BUY	$260.13 - $367.91 $5,462 - $7,726	21 Added 1.87%	1,146 $314,000
Q4 2017 Feb 05, 2018	BUY	$307.64 - $344.58 $27,072 - $30,323	88 Added 8.49%	1,125 $358,000
Q3 2017 Oct 18, 2017	BUY	$281.15 - $329.69 $291,552 - $341,888	1,037	1,037 $325,000

Others Institutions Holding BIIB

# of Institutions

1,050

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

Vanguard Group Inc Valley Forge, PA

16.6M
Shares

$3.23 Billion
0.08% of portfolio
Primecap Management CO Pasadena, CA

16.3M
Shares

$3.18 Billion
2.78% of portfolio
Black Rock Inc. New York, NY

14.5M
Shares

$2.83 Billion
0.08% of portfolio
State Street Corp Boston, MA

7.1M
Shares

$1.38 Billion
0.07% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

5.68M
Shares

$1.11 Billion
0.83% of portfolio

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $28B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Balasa Dinverno & Foltz LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balasa Dinverno & Foltz LLC with notifications on news.

Account